Greater Intermountain Node

Principal Investigators:
Adam J. Gordon, MD, MPH [email]
Gerald Cochran, PhD, MSW [email]
University of Utah
75 South 2000 East
Salt Lake City, UT 84112

Related Resources

Node Newsletter
Node website
NIDA website

The Greater Intermountain Node joined the CTN in 2019. The GIN is housed within the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) within the Division of Epidemiology, Department of Internal Medicine at the University of Utah School of Medicine. The GIN brings particular expertise in 3 areas of opioid addiction research to the Utah, regional, and national communities: 1) research within non-addiction speciality health care settings; 2) addiction and opioid research within large health systems of care; and 3) implementation science and approaches to bring addiction evidence based research to practice.

Grantee Institution: University of Utah

Protocol Involvement

• CTN-0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations (NIH HEAL Initiative)
• CTN-0087: A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration
• CTN-0093: Validation of a Community Pharmacy-based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN)
• CTN-0101: Subthreshold Opioid Use Disorder Prevention (STOP) Trial
• CTN-0138: Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool